UL Prospector
Prospector
Company: Sinerga  Especializados / Otros  Antiinflamatorios  Clear All 

Éxito!

Su búsqueda se ha guardado exitosamente
Since 1978, Sinerga is an Italian contract manufacturer and raw material supplier offering more than 50 cosmetic specialties to the international dermo-cosmetic industry. Sinerga ingredients cover the following categories: actives, emulsifiers, surfactants, texturizers, rheological additives and microbial inhibitors, complying with the main market requirements (China approved, Cosmos, palm oil free, RSPO, preservative free). The extensive know-how and experience in finished product formulation allows Sinerga R&D to offer synergistic formulative support for its own-branded raw materials to create high-quality and market-oriented solutions.
2 Resultados
Eyedren Sinerga
  • INCI Name:
    Ethyl Ximenynate (and) Potassium Lauroyl Wheat Amino Acids (and) Palm Glycerides (and) Capryloyl Glycine
Eyedren is an active ingredient obtained by esterification of Xymenic Acid and carried through lipo amino acids and palm glycerides vesicles to improve its efficacy and bioavailability. Eyedren has proven efficacy in lightening the eye contour, easing dar...Vea Mas Eyedren is an active ingredient obtained by esterification of Xymenic Acid and carried through lipo amino acids and palm glycerides vesicles to improve its efficacy and bioavailability. Eyedren has proven efficacy in lightening the eye contour, easing dark circles and puffiness, and reducing fine lines and wrinkles. Vea Menos
Compliance Highlights Available
 Request Sample
X-SOLVE® Sinerga
  • INCI Name:
    Ethyl Ximenynate (and) Lecithin (and) Caprylic/Capric Triglyceride (and) Glycerin
X-SOLVE® is a high performance skin microcirculation modulator. Thanks to its vasoactive capabilities, it improves blood flow in superficial vessels. It’s obtained by encapsulation by high pressure homogenization of Ethyl Ximenynate into lipophilic vesicl...Vea Mas X-SOLVE® is a high performance skin microcirculation modulator. Thanks to its vasoactive capabilities, it improves blood flow in superficial vessels. It’s obtained by encapsulation by high pressure homogenization of Ethyl Ximenynate into lipophilic vesicles constituted by Lecithin, assuring a better delivery of the active ingredient. Vea Menos
Compliance Highlights Available
 Request Sample